Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Mar 23, 2018
Clinical News

Sun's IL-23 psoriasis mab approved by FDA

BioCentury | Mar 21, 2018
Company News

Sun's IL-23 mAb gets FDA approval for psoriasis

BioCentury | Feb 28, 2018
Distillery Therapeutics

Cancer

BioCentury | Jul 13, 2017
Company News

Almirall lowers guidance

BioCentury | Jul 10, 2017
Financial News

Almirall sags after lowering guidance

BioCentury | May 24, 2017
Clinical News

FDA reviewing Sun's psoriasis candidate

BioCentury | Mar 31, 2017
Clinical News

Tildrakizumab regulatory update

BioCentury | Oct 10, 2016
Clinical News

Tildrakizumab: Additional Phase III data

Items per page:
1 - 10 of 22